242 related articles for article (PubMed ID: 9086433)
1. CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues.
Gruss HJ; Herrmann F; Gattei V; Gloghini A; Pinto A; Carbone A
Leuk Lymphoma; 1997 Feb; 24(5-6):393-422. PubMed ID: 9086433
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease.
Gruss HJ; Hirschstein D; Wright B; Ulrich D; Caligiuri MA; Barcos M; Strockbine L; Armitage RJ; Dower SK
Blood; 1994 Oct; 84(7):2305-14. PubMed ID: 7522624
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
4. The CD40 antigen and its ligand.
Banchereau J; Bazan F; Blanchard D; Brière F; Galizzi JP; van Kooten C; Liu YJ; Rousset F; Saeland S
Annu Rev Immunol; 1994; 12():881-922. PubMed ID: 7516669
[TBL] [Abstract][Full Text] [Related]
5. Functions of CD40 and its ligand, gp39 (CD40L).
Laman JD; Claassen E; Noelle RJ
Crit Rev Immunol; 1996; 16(1):59-108. PubMed ID: 8809473
[TBL] [Abstract][Full Text] [Related]
6. Functions of CD40 and Its Ligand, gp39 (CD40L).
Laman JD; Claassen E; Noelle RJ
Crit Rev Immunol; 2017; 37(2-6):371-420. PubMed ID: 29773027
[TBL] [Abstract][Full Text] [Related]
7. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
Wykes M; Poudrier J; Lindstedt R; Gray D
Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.
Clodi K; Asgari Z; Younes M; Palmer JL; Cabanillas F; Carbone A; Andreeff M; Younes A
Cancer; 2002 Jan; 94(1):1-5. PubMed ID: 11815953
[TBL] [Abstract][Full Text] [Related]
10. CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1).
Ramesh N; Morio T; Fuleihan R; Worm M; Horner A; Tsitsikov E; Castigli E; Geha RS
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S208-13. PubMed ID: 7554470
[TBL] [Abstract][Full Text] [Related]
11. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.
Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A
Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508
[TBL] [Abstract][Full Text] [Related]
12. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions.
Denépoux S; Fournier N; Péronne C; Banchereau J; Lebecque S
J Immunol; 2000 Feb; 164(3):1306-13. PubMed ID: 10640744
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells.
Clodi K; Asgary Z; Zhao S; Kliche KO; Cabanillas F; Andreeff M; Younes A
Br J Haematol; 1998 Oct; 103(1):270-5. PubMed ID: 9792321
[TBL] [Abstract][Full Text] [Related]
14. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.
Mach F; Schönbeck U; Sukhova GK; Bourcier T; Bonnefoy JY; Pober JS; Libby P
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1931-6. PubMed ID: 9050882
[TBL] [Abstract][Full Text] [Related]
15. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
Gruss HJ; Duyster J; Herrmann F
Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
[TBL] [Abstract][Full Text] [Related]
16. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias.
Carbone A; Gloghini A; Zagonel V; Aldinucci D; Gattei V; Degan M; Improta S; Sorio R; Monfardini S; Pinto A
Blood; 1995 Dec; 86(12):4617-26. PubMed ID: 8541553
[TBL] [Abstract][Full Text] [Related]
17. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.
Seyama K; Nonoyama S; Gangsaas I; Hollenbaugh D; Pabst HF; Aruffo A; Ochs HD
Blood; 1998 Oct; 92(7):2421-34. PubMed ID: 9746782
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
Aversa G; Punnonen J; Carballido JM; Cocks BG; de Vries JE
Semin Immunol; 1994 Oct; 6(5):295-301. PubMed ID: 7532459
[TBL] [Abstract][Full Text] [Related]
20. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".
Kroczek RA; Graf D; Brugnoni D; Giliani S; Korthüer U; Ugazio A; Senger G; Mages HW; Villa A; Notarangelo LD
Immunol Rev; 1994 Apr; 138():39-59. PubMed ID: 7915248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
